Resolution Therapeutics
PrivateLast Round
Series B
Oct 3, 2024
Total Funding Raised
$132.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Resolution Therapeutics is a biotechnology company developing regenerative macrophage cell therapies to treat inflammatory and fibrotic diseases, with an initial focus on end-stage liver disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resolution Therapeutics Comparables
Compare Resolution Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carisma Therapeutics | 77% | |
| KanonCure Inc. | 73% | |
| HepaTx Corporation | 70% |
Resolution Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 3, 2024 | ||||
| Series A Extension | Apr 5, 2022 | ||||
| Series A | Dec 2, 2020 |
Resolution Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Series B, Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 55% MoM, reaching 2.6K.
- Oct 9, 2025
Will present at The Liver Meeting 2025 by AASLD.
Recent news
Latest coverage and updates
- is_developingSep 1, 2026
Resolution Tx is developing Regenerative Macrophage Therapy on Aug 25th '26.
- is_developingSep 1, 2026
Resolution Tx is developing RMTs in additional inflammatory and fibrotic indications.
- partners_withSep 1, 2026
Resolution Tx partnered with Blood Centers of America on Sep 1st '26.
Resolution Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Resolution Therapeutics's valuation, stock price, and market status.
Is Resolution Therapeutics a public or private company?
Resolution Therapeutics is a private company.
What is the current stock price of Resolution Therapeutics?
Resolution Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Resolution Therapeutics worth (valuation)?
Valuation information for Resolution Therapeutics is not publicly available.
Can I buy Resolution Therapeutics stock?
Resolution Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Resolution Therapeutics's last funding round?
Resolution Therapeutics's most recent funding round was Series B on October 3, 2024.
Who are the main investors in Resolution Therapeutics?
Key investors in Resolution Therapeutics include Syncona.
Will Resolution Therapeutics IPO soon?
No public IPO plans have been announced for Resolution Therapeutics.
How can I track Resolution Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Resolution Therapeutics's secondary market activity and sign up for updates.